Zurück| Startseite > Veranstaltungen > Fortbildung > VACCELERATE webinar: Inhibition of SARS-CoV-2 Omicron BA.1 and BA.4 Variants after fourth Vaccination or Tixagevimab and Cilgavimab Administration in Cancer Patients
VACCELERATE webinar: Inhibition of SARS-CoV-2 Omicron BA.1 and BA.4 Variants after fourth Vaccination or Tixagevimab and Cilgavimab Administration in Cancer Patients
Speaker: Dr. med. univ. Maximilian Mair, Medical University Vienna, Austria